COVID‐19 plasma proteome reveals novel temporal and cell‐specific signatures for disease severity and high‐precision disease management

Coronavirus disease 2019 (COVID‐19) is a systemic inflammatory condition with high mortality that may benefit from personalized medicine and high‐precision approaches. COVID‐19 patient plasma was analysed with targeted proteomics of 1161 proteins. Patients were monitored from Days 1 to 10 of their i...

Descripción completa

Detalles Bibliográficos
Autores principales: Iosef, Cristiana, Martin, Claudio M., Slessarev, Marat, Gillio‐Meina, Carolina, Cepinskas, Gediminas, Han, Victor K. M., Fraser, Douglas D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806290/
https://www.ncbi.nlm.nih.gov/pubmed/36537107
http://dx.doi.org/10.1111/jcmm.17622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806290/
https://www.ncbi.nlm.nih.gov/pubmed/36537107
http://dx.doi.org/10.1111/jcmm.17622

Ejemplares similares